Prognostic and predictive biomarkers in CLL and their potential in guiding treatment decisions VJHemOnc – Video Journal of Hematology & HemOnc 1:26 6 days ago 39 Далее Скачать
The efficacy of CAR T-cell therapy in Richter’s transformation VJHemOnc – Video Journal of Hematology & HemOnc 1:16 6 days ago 91 Далее Скачать
Challenges in monitoring for cardiotoxicity when treating patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:40 6 days ago 26 Далее Скачать
Pericardial adverse events associated with BTKis in CLL: insights from two landmark trials VJHemOnc – Video Journal of Hematology & HemOnc 1:12 6 days ago 34 Далее Скачать
Preclinical efficacy of the PKCβ inhibitor MS-553 in BTKi resistant CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:46 1 year ago 124 Далее Скачать
The mutational profile in patients with CLL treated with acalabrutinib or ibrutinib VJHemOnc – Video Journal of Hematology & HemOnc 1:34 6 days ago 59 Далее Скачать
Defining high-risk CLL: known and emerging mutations VJHemOnc – Video Journal of Hematology & HemOnc 1:04 1 year ago 550 Далее Скачать
Seizing the day with BTK inhibitors in CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:29 3 years ago 237 Далее Скачать
Considering patient preference when selecting between continuous and time-limited therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:49 1 year ago 37 Далее Скачать
Acalabrutinib vs ibrutinib in R/R CLL: assessing the burden of adverse events VJHemOnc – Video Journal of Hematology & HemOnc 1:53 1 year ago 224 Далее Скачать
Comparing ibrutinib efficacy and toxicity levels by age for patients with CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 7 years ago 336 Далее Скачать
Moving towards personalized therapy in CLL & sequencing BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:09 1 year ago 106 Далее Скачать
Pirtobrutinib in patients with CLL/SLL previously exposed to covalent BTKi: insights from BRUIN VJHemOnc – Video Journal of Hematology & HemOnc 1:18 10 months ago 310 Далее Скачать
The prognostic value of karyotypic complexity in ibrutinib-treated CLL patients VJHemOnc – Video Journal of Hematology & HemOnc 1:44 3 years ago 63 Далее Скачать
Speaker: Jennifer Hearne - APM Project Management Conference 2017 Association for Project Management 2:07 7 years ago 345 Далее Скачать
6-year follow-up of ELEVATE-TN: sustained safety and efficacy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:04 10 months ago 297 Далее Скачать
Emerging ibrutinib-based combinations in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 73 Далее Скачать
The future role of MRD measurement in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:58 3 years ago 34 Далее Скачать
Overcoming resistance to BTK inhibition in CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:11 4 years ago 135 Далее Скачать
